RFP
TNGX icon

Root Financial Partners’s Tango Therapeutics TNGX Stock Holding History

Root Financial Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34
Closed -$711 – 2938
2026
Q1 		$711 Buy
+34
New +$473 ﹤0.01% 2742

Other funds holding TNGX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

Root Financial Partners's TNGX Position: Q2 2026 in Review

Root Financial Partners sold out of Tango Therapeutics (TNGX) in Q2 2026, closing a stake of 34 shares — an estimated $711 sold.

Root Financial Partners first reported a position in TNGX in Q1 2026 and held it in 1 quarter. The position peaked at $711 in Q1 2026. 28 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Root Financial Partners reported no remaining Tango Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 34 Tango Therapeutics shares in Q2 2026, an estimated $711.
  • Root Financial Partners first reported a position in Tango Therapeutics in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Tango Therapeutics position peaked at $711 in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.